Cargando…
Mechanisms of chronic alcohol exposure-induced aggressiveness in cellular model of HCC and recovery after alcohol withdrawal
Alcohol-related liver disease is the most prevalent chronic liver disease worldwide, accounting for 30% of hepatocellular carcinoma (HCC) cases and HCC-specific deaths. However, the knowledge on mechanisms by which alcohol consumption leads to cancer progression and its aggressiveness is limited. Be...
Autores principales: | Marié, Constance, Fouquet, Grégory, Courtois, Anoïsia, Amrathlal, Rabbind Singh, Jankovsky, Nicolas, Ouled-Haddou, Hakim, Tebbakha, Riad, Bouhlal, Hicham, Nguyen-Khac, Éric, Naassila, Mickaël, Marcq, Ingrid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205837/ https://www.ncbi.nlm.nih.gov/pubmed/35713728 http://dx.doi.org/10.1007/s00018-022-04387-y |
Ejemplares similares
-
Hepatocyte SLAMF3 reduced specifically the multidrugs resistance protein MRP-1 and increases HCC cells sensitization to anti-cancer drugs
por: Fouquet, Grégory, et al.
Publicado: (2016) -
Rescuing SLAMF3 Expression Restores Sorafenib Response in Hepatocellular Carcinoma Cells through the Induction of Mesenchymal-to-Epithelial Transition
por: Fouquet, Grégory, et al.
Publicado: (2022) -
Signaling lymphocytic activation molecules Slam and cancers: friends or foes?
por: Fouquet, Gregory, et al.
Publicado: (2018) -
RB/PLK1-dependent induced pathway by SLAMF3 expression inhibits mitosis and control hepatocarcinoma cell proliferation
por: Bouhlal, Hicham, et al.
Publicado: (2016) -
Identification of SLAMF3 (CD229) as an Inhibitor of Hepatocellular Carcinoma Cell Proliferation and Tumour Progression
por: Marcq, Ingrid, et al.
Publicado: (2013)